Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
11. November 2024
3 min to read

Deep-learning Assisted ECG-based Emergent Cathlab Activation: First Prospective Implementation of a Smartphone-based System

Deep-learning Assisted ECG-based Emergent Cathlab Activation

Overview

In its first prospective performance evaluation, the PMcardio STEMI AI ECG Model outperformed standard ECG machine readings, detecting high-risk coronary blockage with 95.7% sensitivity vs. 47.8%. By correctly flagging 15 initially missed patients, the AI model demonstrated its potential to strengthen triage accuracy and accelerate life-saving decisions.

Published In: Circulation (AHA Journals) – presented at the American Heart Association (AHA) 2024 Scientific Sessions
Presented Date: November 11, 2024

Background

Standard ST-segment elevation myocardial infarction (STEMI) pathways misidentify up to 50% of patients with an acutely occluded culprit coronary artery (OMI) with false positive emergent cathlab activations in up to 35% of cases. Recently, an artificial intelligence (AI) electrocardiogram (ECG) model outperformed standard of care in detecting OMI in international retrospective cohorts.

We sought to prospectively evaluate the rule-in performance of an AI ECG model in a large tertiary care STEMI network compared to ECG machine readings of STEMI and AI-assisted emergency physicians.

Methods

An AI model trained to detect acute coronary occlusion regardless of ST elevation was implemented using smartphones in a tertiary care STEMI network consisting of 1 hub hospital, 1 spoke center, and 2 emergency medical service crews (EMS) (Fig 1A). Outcomes of all patients presenting with atraumatic chest pain during a 10-week period between January and March 2024 were adjudicated using ECG, laboratory, and angiographic chart review and classified based on the presence of OMI.

Results

A total of 731 consecutive patients (68% male) with atraumatic chest pain were included; 142 patients were hospitalized of whom 23 (16%) met the primary outcome of OMI. The AI model showed a significantly higher sensitivity detecting OMI as compared to ECG machine (95.7% vs. 47.8%, p<0.001, Fig 1B) at comparable specificity (95% vs. 96%, respectively) with overall superior predictive accuracy (Chi-squared=8.1; p=0.004). The AI model correctly identified 15 cases that the ECG machine misclassified (80% were false negatives by ECG machine). All AI false positives were patients post recent myocardial infarction or angioplasty. Sensitivity of AI-assisted emergency physicians interpreting OMI was 78.2% indicating potential instances of AI underutilization.

Conclusion

This first prospective performance evaluation in a large all-comer atraumatic chest pain cohort indicates high accuracy of unbiased, AI-powered ECG detecting acute coronary occlusion. The findings suggest its potential to improve ACS patient outcomes through timely referral for invasive management in a real-world clinical setting.


Authors: Robert Herman, MD, Rinaldo Lauwers, MD, David Pletnickx, MA, Harvey Meyers, MD, Stephen Smith, MD, Timea Kisova, MD, BSC, Anthony Demolder, MD, MSc, PhD, Peter Herman, Student, Radka Grendova, MA, Monika Beles, MS, Leor Perl, BSC, MD, Olivier Nelis, BSC, Emanuele Barbato, MD, Jozef Bartunek, MD, Dan Schelfaut, MD

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

An AI Model for Electrocardiogram Detection of Occlusion Myocardial Infarction: A Retrospective Study to Reduce False Positive Cath Lab Activations

This single-centre retrospective study examined whether an AI-powered ECG model (PMcardio’s Queen of Hearts OMI model) can better detect acute occlusion myocardial infarction (OMI) and reduce false-positive cardiac catheterization laboratory (CCL) activations compared with traditional STEMI millimetre criteria. The authors analysed 304 consecutive STEMI pathway activations over a 2-year period at a tertiary academic centre and applied the AI model to pre-angiography 12-lead ECGs, comparing its performance against standard STEMI criteria. The AI model showed higher sensitivity (89.2% vs 68.3%), higher specificity (72.9% vs 51.7%), greater overall accuracy (82.9% vs 61.8%), and a high AUROC of 0.884 for identifying true OMI, while correctly flagging nearly three-quarters of false-positive activations as non-OMI. These findings suggest that integrating a specialized AI-ECG model into existing STEMI alert pathways could meaningfully reduce unnecessary CCL activations without compromising the detection of true occlusions.

Bifascicular Block Associated With Myocardial Infarction: A Marker of Proximal Left Anterior Descending Artery Occlusion Confirmed by the Artificial Intelligence-Based Smartphone App Queen of Hearts

This single-patient case report describes an elderly man presenting with chest pain, hypotension, and bifascicular block (BFB)—a combination of right bundle branch block (RBBB) and left anterior fascicular block (LAFB)—whose ECG showed QRS‑concordant anterior and lateral ST‑segment elevation consistent with a STEMI‑equivalent / occlusive myocardial infarction (OMI) pattern. Urgent coronary angiography revealed a long, severely calcified, near‑occlusive proximal left anterior descending (LAD) artery lesion, successfully treated with primary PCI and drug‑eluting stent implantation, achieving TIMI 3 flow. The Queen of Hearts (PMcardio) AI‑based smartphone app correctly classified the ECG as STEMI‑equivalent, identified atrial flutter and BFB, and predicted reduced left ventricular ejection fraction, later confirmed by echocardiography (EF 38%). This case underscores BFB with concordant anterior ST elevation as a high‑risk marker of proximal LAD‑culprit OMI and provides anecdotal evidence that specialized AI‑enabled ECG interpretation can support rapid, accurate decision‑making in ACS. 

Join over 100,000 healthcare professionals who are already taking advantage of AI